https://sb216763inhibitor.com/....intensification-of-c
The mortality rates for severe myeloid leukemia are very high, necessitating the look for unique chemotherapeutic applicants. Herein, we investigated the anticancer potential of a unique synthetic compound, 2-ethyl-3-methyliden-1-tosyl-2,3-dihydroquinolin-4-(1H)-one (AJ-374) against myeloid leukemia HL-60 cellular line. This analog was selected through the little collection of artificial dihydroquinolinones based on its strong antiproliferative task against HL-60 cells and 30-fold lower cytotoxic
Like
Comment
Share
